Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 3 Prostatic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Neoplasm Metastasis 1 Microsatellite-stable Colorectal Cancer 1 Melanoma 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Glioblastoma 1 Genital Neoplasms, Female 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Hepatocellular 1 Advanced Renal Cell Carcinoma 1 Adenocarcinoma of Lung 1

Interventions

balstilimab 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Advanced Renal Cell Carcinoma × Nivolumab × Clear all

NCT05928806 2026-02-11

ARCITECT

Hoosier Cancer Research Network

Phase 2 Suspended

Advanced Renal Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡